ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

BNR Burning Rock Biotech Ltd

0.807
0.0484 (6.38%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Burning Rock Biotech Ltd BNR NASDAQ Certificado de Depósito
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.0484 6.38% 0.807 23:00:10
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.7899 0.7361 0.8199 0.807 0.7586
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
29/4/202402:30GLOBEBurning Rock Publishes 2023 Annual Report on Form 20-F
26/4/202400:59GLOBEBurning Rock Announces ADS Ratio Change
28/3/202416:16GLOBEBurning Rock Reports Fourth Quarter and Full Year 2023..
14/2/202411:45EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
10/1/202415:08EDGAR2Form SC 13G - Statement of acquisition of beneficial..
04/1/202405:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/1/202400:03GLOBEBurning Rock Announces Receipt of Notification from NASDAQ
20/12/202305:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19/12/202320:35GLOBEBurning Rock Announces Results of 2023 Annual General..
30/11/202305:08EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/11/202300:25GLOBEBurning Rock Reports Third Quarter 2023 Financial Results
22/11/202305:08EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22/11/202301:04GLOBEBurning Rock Announces 2023 Annual General Meeting to be..
20/11/202319:55GLOBEBurning Rock Schedules Third Quarter of 2023 Earnings..
30/10/202302:20GLOBEBurning Rock and Boehringer Ingelheim Achieved a Master..
15/10/202318:18GLOBEBurning Rock Received Breakthrough Device Designation from..
07/9/202321:43GLOBEBurning Rock's minimal residual disease (MRD) product..
05/9/202305:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/8/202300:30GLOBEBurning Rock Reports Second Quarter 2023 Financial Results
04/8/202302:27GLOBEBurning Rock Provides Second Quarter 2023 Business Updates..
28/6/202303:05GLOBEBurning Rock Announces Resignation and Appointment of..
07/6/202323:20GLOBEBurning Rock's precision oncology diagnostics product..
29/5/202323:53GLOBEBurning Rock Reports First Quarter 2023 Financial Results

Su Consulta Reciente

Delayed Upgrade Clock